{"cdcTestId":"2013-0503","testcaseName":"Dose 1 to dose 2 interval 8 wks-5 days","vaccineGroup":"MCV","evaluationTestType":"Interval: Below Absolute Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2011-06-29T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-08-29T00:00:00","vaccineName":"meningococcal MCV4, unspecified formulation","cvx":"147","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"meningococcal MCV4, unspecified formulation","cvx":"147","mvx":"","evaluationStatus":"Not Valid","evaluationReason":"Interval: too short"}]},"forecast":{"forecastNum":"2","earliestDate":"2027-06-29T00:00:00","recommendedDate":"2027-06-29T00:00:00","pastDueDate":"2028-07-26T00:00:00"},"doses":[{"dateAdministered":"2022-08-29T00:00:00","vaccineName":"meningococcal MCV4, unspecified formulation","cvx":"147","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"meningococcal MCV4, unspecified formulation","cvx":"147","mvx":"","evaluationStatus":"Not Valid","evaluationReason":"Interval: too short"}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2018-04-23T14:41:49.054","generalDescription":"This test case describes when dose #2 of a Mening vaccine is administered too early (8 weeks - 5 days after dose #1), that the dose is not valid.","changedInVersion":"1.6","reasonForChange":"v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated.  The second dose must come on or after 16 years (- 4 days) of age to be considered valid."}